131 related articles for article (PubMed ID: 38691385)
1. Relevance of Human Herpesvirus 6 Reactivation in Drug Rash With Eosinophilia and Systemic Symptoms-Reply.
Brüggen MC; Ingen-Housz-Oro S
JAMA Dermatol; 2024 Jun; 160(6):687-688. PubMed ID: 38691385
[No Abstract] [Full Text] [Related]
2. Relevance of Human Herpesvirus 6 Reactivation in Drug Rash With Eosinophilia and Systemic Symptoms.
Zhu H; Komaroff AL; Ren V
JAMA Dermatol; 2024 Jun; 160(6):687. PubMed ID: 38691374
[No Abstract] [Full Text] [Related]
3. Drug eruption with eosinophilia and systemic syndrome associated with reactivation of human herpesvirus 7, not human herpesvirus 6.
Morito H; Kitamura K; Fukumoto T; Kobayashi N; Kuwahara M; Asada H
J Dermatol; 2012 Jul; 39(7):669-70. PubMed ID: 22077365
[No Abstract] [Full Text] [Related]
4. Latent Hepatitis Virus Reactivation Due to Drug Reaction: DRESSed to Kill?
Alexanian D; Birg A; Volpicelli N; Glass J; McCarthy D
Dig Dis Sci; 2018 May; 63(5):1143-1147. PubMed ID: 29594978
[No Abstract] [Full Text] [Related]
5. Facial paralysis associated with drug reaction with eosinophilia and systemic symptoms (DRESS) with oxcarbazepine and reactivation of human herpesvirus 6 (HHV-6).
Kluger N; Descamps V; Lappalainen K; Roivainen R
Int J Dermatol; 2020 Apr; 59(4):e114-e115. PubMed ID: 31840232
[No Abstract] [Full Text] [Related]
6. Acute hepatic failure in trimethoprim-induced drug rash with eosinophilia and systemic symptoms (DRESS).
Connolly A; Walsh S; Philippidou M; Salisbury J; Creamer D
Br J Dermatol; 2023 Jul; 189(1):140-141. PubMed ID: 36946217
[No Abstract] [Full Text] [Related]
7. A fatal case of DRESS induced by strontium ranelate associated with HHV-7 reactivation.
Drago F; Cogorno L; Broccolo F; Ciccarese G; Parodi A
Osteoporos Int; 2016 Mar; 27(3):1261-1264. PubMed ID: 26519419
[TBL] [Abstract][Full Text] [Related]
8. Human herpesvirus 6 lymphadenitis in drug rash with eosinophilia and systemic symptoms syndrome: a lymphoma mimic.
Johnson S; Mathews S; Hudnall SD
Histopathology; 2017 Jun; 70(7):1166-1170. PubMed ID: 28008656
[TBL] [Abstract][Full Text] [Related]
9. Drug Reaction with Eosinophilia and Systemic Symptoms or Virus Reactivation with Eosinophilia and Systemic Symptoms.
Descamps V; Brunet-Possenti F
Pediatr Dermatol; 2016 Sep; 33(5):562. PubMed ID: 27595878
[No Abstract] [Full Text] [Related]
10. Case report of drug rash with eosinophilia and systemic symptoms demonstrating human herpesvirus-6 reactivation.
Ferrero NA; Pearson KC; Zedek DC; Morrell DS
Pediatr Dermatol; 2013; 30(5):608-13. PubMed ID: 24016284
[TBL] [Abstract][Full Text] [Related]
11. Active human herpesvirus 6 infection in a patient with drug rash with eosinophilia and systemic symptoms.
Descamps V; Collot S; Mahé E; Houhou N; Crickx B; Ranger-Rogez S
J Invest Dermatol; 2003 Jul; 121(1):215-6. PubMed ID: 12839588
[No Abstract] [Full Text] [Related]
12. Cascade of Drug Toxicities: A Challenging Case of Tuberculosis and Drug Rash with Eosinophilia and Systemic Symptoms.
Kodan P; Gupta N; Narang H; Singh A; Fazal F; Khot W; Soneja M; Biswas A; Wig N
J Assoc Physicians India; 2022 Sep; 70(9):11-12. PubMed ID: 36082900
[No Abstract] [Full Text] [Related]
13. HHV-6 lymphadenitis with DRESS syndrome: another lymphoma mimic.
Flaifel A; Rocco JM
Blood; 2024 Jun; 143(25):2671. PubMed ID: 38900479
[No Abstract] [Full Text] [Related]
14. Evidence for reactivation of human herpesvirus 6 in generalized lymphadenopathy in a patient with drug-induced hypersensitivity syndrome.
Saraya T; Mikoshiba M; Kamiyama H; Yoshizumi M; Tsuchida S; Tsukagoshi H; Ishioka T; Terada M; Tanabe E; Tomioka C; Ishii H; Kimura H; Kozawa K; Shiohara T; Takizawa H; Goto H
J Clin Microbiol; 2013 Jun; 51(6):1979-82. PubMed ID: 23536404
[TBL] [Abstract][Full Text] [Related]
15. Case 26-2018: A 48-Year-Old Man with Fever, Chills, Myalgias, and Rash.
Turbett SE; Tsiaras WG; McDermott S; Eng G
N Engl J Med; 2018 Aug; 379(8):775-785. PubMed ID: 30134139
[No Abstract] [Full Text] [Related]
16. TNF-α as a useful predictor of human herpesvirus-6 reactivation and indicator of the disease process in drug-induced hypersensitivity syndrome (DIHS)/drug reaction with eosinophilia and systemic symptoms (DRESS).
Uno H; Kabashima K; Tohyama M; Watanabe T; Hashimoto K; Iijima M; Sueki H; Watanabe H
J Dermatol Sci; 2014 May; 74(2):177-9. PubMed ID: 24517870
[No Abstract] [Full Text] [Related]
17. Occupational trichloroethylene hypersensitivity syndrome: human herpesvirus 6 reactivation and rash phenotypes.
Kamijima M; Wang H; Yamanoshita O; Ito Y; Xia L; Yanagiba Y; Chen C; Okamura A; Huang Z; Qiu X; Song X; Cai T; Liu L; Ge Y; Deng Y; Naito H; Yoshikawa T; Tohyama M; Li L; Huang H; Nakajima T
J Dermatol Sci; 2013 Dec; 72(3):218-24. PubMed ID: 23928230
[TBL] [Abstract][Full Text] [Related]
18. Leukapheresis in the management of drug rash with eosinophilia and systemic symptoms syndrome.
Martínez de Lagrán I; Marcos P; Batlle M; Alonso E; Plana A; Tomasa T
Med Intensiva; 2017 Apr; 41(3):191-193. PubMed ID: 27017438
[No Abstract] [Full Text] [Related]
19. Trimethoprim-sulfamethoxazole-induced hypersensitivity syndrome associated with reactivation of human herpesvirus-6.
Morimoto T; Sato T; Matsuoka A; Sakamoto T; Ohta K; Ando T; Ikushima S; Hagiwara K; Matsuno H; Akiyama O; Oritsu M
Intern Med; 2006; 45(2):101-5. PubMed ID: 16484748
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms or non-drug-related erythroderma with a persistent human herpesvirus 6 infection.
Mitsui Y; Ogawa K; Miyagawa F; Azukizawa H; Yoshikawa T; Asada H
J Dermatol; 2020 Feb; 47(2):e44-e46. PubMed ID: 31696531
[No Abstract] [Full Text] [Related]
[Next] [New Search]
